Rat injury model of docetaxel extravasation

Zhu,Jing‑Jing; Fu,Jian‑Fei; Yang,Jiao; Hu,Bing; Zhang,Hui; Yu,Jian‑Hua

doi:10.3892/br.2014.292

September-October 2014 Volume 2 Issue 5

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

September-October 2014 Volume 2 Issue 5

Full Size Image

Article

Rat injury model of docetaxel extravasation

Authors:
- Jing‑Jing Zhu
- Jian‑Fei Fu
- Jiao Yang
- Bing Hu
- Hui Zhang
- Jian‑Hua Yu
View Affiliations / Copyright

Affiliations: Department of Rehabilitation, Jinhua Central Hospital (Jinhua Hospital of Zhejiang University), Jinhua, Zhejiang 321000, P.R. China, Department of Oncology, Jinhua Central Hospital (Jinhua Hospital of Zhejiang University), Jinhua, Zhejiang 321000, P.R. China, Cancer Institute, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, P.R. China, Department of Pathology, Jinhua Central Hospital (Jinhua Hospital of Zhejiang University), Jinhua, Zhejiang 321000, P.R. China, Jinhua Food and Drug Administration, Jinhua, Zhejiang 321000, P.R. China
Pages: 649-652
|
Published online on: May 26, 2014

https://doi.org/10.3892/br.2014.292
Expand metrics +

Abstract

Docetaxel is a novel type of chemotherapy drug that actively treats a number of malignant tumors. The aim of the present study was to explore the severity and natural course of tissue damage induced by docetaxel extravasation and to confirm the vesicant potential of docetaxel. Rats were selected for the establishment of the ulcer model. Different volumes and concentrations were explored to induce the skin ulcer and to confirm the optimum rational injection model. The natural course of tissue injury and pathological changes produced by docetaxel extravasation were observed by comparing to vinorelbine extravasation. A 0.4 ml volume and a 6 mg/ml concentration were the optimum rational injection model for the induction of the skin ulcer. The docetaxel extravasation induced local tissue necrosis, followed by granuloma formation and hyperpigmentation or scar formation. The severity of the injury depended on the concentration of the extravasation used in the rat model. The injury occurred on the first day following extravasation and lasted 4?6 weeks. The damage from docetaxel was weaker than vinorelbine in association with the depth and extension of necrosis. In conclusion, docetaxel extravasation can induce tissue necrosis. However, the severity of necrosis was weaker than that of vinorelbine. Docetaxel has superficial vesicant properties.

View Figures

View References

1	Mackey JR, Martin M, Pienkowski T, et al; TRIO/BCIRG 001 investigators. Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial. Lancet Oncol. 14:72–80. 2013.PubMed/NCBI
2	Fossella F, Pereira JR, von Pawel J, et al: Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group. J Clin Oncol. 21:3016–3024. 2003. View Article : Google Scholar : PubMed/NCBI
3	Vermorken JB, Remenar E, van Herpen C, et al; EORTC 24971/TAX 323 Study Group. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med. 357:1695–1704. 2007. View Article : Google Scholar : PubMed/NCBI
4	Van Cutsem E, Moiseyenko VM, Tjulandin S, et al; V325 Study Group. Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group. J Clin Oncol. 24:4991–4997. 2006.PubMed/NCBI
5	Yilmaz M, Demirdover C and Mola F: Treatment options in extravasation injury: an experimental study in rats. Plast Reconstr Surg. 109:2418–2423. 2002. View Article : Google Scholar : PubMed/NCBI
6	Bowers DG Jr and Lynch JB: Adriamycin extravasation. Plast Reconstr Surg. 61:86–92. 1978. View Article : Google Scholar
7	Dorr RT and Bool KL: Antidote studies of vinorelbine-induced skin ulceration in the mouse. Cancer Chemother Pharmacol. 36:290–292. 1995. View Article : Google Scholar : PubMed/NCBI
8	Dorr RT, Snead K and Liddil JD: Skin ulceration potential of paclitaxel in a mouse skin model in vivo. Cancer. 78:152–156. 1996. View Article : Google Scholar : PubMed/NCBI
9	Payne AS, James WD and Weiss RB: Dermatologic toxicity of chemotherapeutic agents. Semin Oncol. 33:86–97. 2006. View Article : Google Scholar : PubMed/NCBI
10	Gallo E, Llamas-Velasco M, Navarro R, Fraga J and García-Diez A: Eccrine squamous syringometaplasia secondary to cutaneous extravasation of docetaxel: report of three cases. J Cutan Pathol. 40:326–329. 2013.PubMed/NCBI
11	Kramer F, Schippert C, Rinnau F, Hillemanns P and Park-Simon TW: The first description of docetaxel-induced recall inflammatory skin reaction after previous drug extravasation (February). Ann Pharmacother. Jan 25–2011.(Epub ahead of print).
12	Ley BD, Millán GG, Perez JS, Fraga J and Díez AG: Docetaxel recall phenomenon at the site of previous drug extravasation. Arch Dermatol. 146:1190–1191. 2010.PubMed/NCBI
13	Cifuentes L, Ring J and Brockow K: Extravasation of docetaxel. J Dtsch Dermatol Ges. 10:662–663. 2012.(In English, German).
14	Barceló R, Viteri A, Muñoz A, Carrera S, Rubio I and López-Vivanco G: Extravasation of docetaxel: a red hand syndrome. Arch Dermatol. 141:1326–1327. 2005.PubMed/NCBI
15	El Saghir NS and Otrock ZK: Docetaxel extravasation into the normal breast during breast cancer treatment. Anticancer Drugs. 15:401–404. 2004.PubMed/NCBI
16	Ho CH, Yang CH and Chu CY: Vesicant-type reaction due to docetaxel extravasation. Acta Derm Venereol. 83:467–468. 2003. View Article : Google Scholar : PubMed/NCBI
17	Berghammer P, Pöhnl R, Baur M and Dittrich C: Docetaxel extravasation. Support Care Cancer. 9:131–134. 2001. View Article : Google Scholar : PubMed/NCBI
18	Raley J, Geisler JP, Buekers TE and Sorosky JI: Docetaxel extravasation causing significant delayed tissue injury. Gynecol Oncol. 78:259–260. 2000. View Article : Google Scholar : PubMed/NCBI
19	Ascherman JA, Knowles SL and Attkiss K: Docetaxel (taxotere) extravasation: a report of five cases with treatment recommendations. Ann Plast Surg. 45:438–441. 2000. View Article : Google Scholar : PubMed/NCBI
20	Chu CY, Yang CH, Yang CY, Hsiao GH and Chiu HC: Fixed erythrodysaesthesia plaque due to intravenous injection of docetaxel. Br J Dermatol. 142:808–811. 2000. View Article : Google Scholar : PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Rat injury model of docetaxel extravasation

This article is mentioned in:

Abstract

Figure 1

Figure 2

Related Articles